PRESS RELEASE published on 05/07/2025 at 14:45, 1 year 1 month ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses 1.0974% stake in Alpha Group International plc according to Form 8.3. Details on positions and dealings provided Securities Form 8.3 Disclosure Lupus Alpha Asset Management AG Alpha Group International Plc
BRIEF published on 07/22/2024 at 12:05, 1 year 11 months ago Lupus Alpha Asset Management AG Discloses Position in Crest Nicholson Holdings Plc Takeover Code Stock Sale Investment Disclosure Crest Nicholson Lupus Alpha
BRIEF published on 07/22/2024 at 12:05, 1 year 11 months ago Lupus Alpha Asset Management AG dévoile sa position dans Crest Nicholson Holdings Plc Code De Reprise Vente D'actions Divulgation Des Investissements Crête Nicholson Lupus Alpha
PRESS RELEASE published on 07/22/2024 at 12:00, 1 year 11 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.9409% stake in Crest Nicholson Holdings Plc. Details per UK Takeover Code Rule 8.3 on 22-Jul-2024 Disclosure Takeover Code Stake Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 07/19/2024 at 15:35, 1 year 11 months ago Lupus Alpha Asset Management AG Discloses Interest in Crest Nicholson Holdings Plc Asset Management Takeover Code Securities Disclosure Crest Nicholson Lupus Alpha
BRIEF published on 07/19/2024 at 15:35, 1 year 11 months ago Lupus Alpha Asset Management AG divulgue son intérêt dans Crest Nicholson Holdings Plc Code De Reprise Divulgation Des Titres La Gestion D'actifs Crête Nicholson Lupus Alpha
PRESS RELEASE published on 07/19/2024 at 15:30, 1 year 11 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.9615% ownership position in Crest Nicholson Holdings Plc. Details of the disclosure per Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Ownership Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 07/15/2024 at 12:35, 1 year 11 months ago Lupus Alpha Asset Management AG : Divulgation sur Crest Nicholson Holdings Plc Divulgation Code De Reprise Crest Nicholson Holdings Gestion D'actifs Lupus Alpha Position Publique
BRIEF published on 07/15/2024 at 12:35, 1 year 11 months ago Lupus Alpha Asset Management AG: Disclosure on Crest Nicholson Holdings Plc Disclosure Takeover Code Crest Nicholson Holdings Lupus Alpha Asset Management Public Position
PRESS RELEASE published on 07/15/2024 at 12:30, 1 year 11 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses 3.93% stake in Crest Nicholson Holdings Plc. Public position disclosure under Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Takeover Code Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
Published on 06/26/2026 at 14:05, 3 hours 33 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 38 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 38 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 53 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 17:05, 33 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 38 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 15:30, 2 hours 7 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 2 hours 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 38 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 38 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
